1.350USD+6.30%Mkt Cap: 419.62M $P/E: —2d ago
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single mol…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap419.62M $
Enterprise Value854.58M $
Revenue (TTM)159.27M $
Gross Profit45.78M $
Net Income (TTM)-546.38M $
Revenue/Share0.5230 USD
Last Price1.350 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees485
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS69404D1081
Valuation
P/E (Trailing)—
P/E (Forward)-3.04
PEG—
EV/EBITDA4.29
EV/Revenue5.37
P/S2.40
P/B-11.50
EPS (TTM)-0.41
EPS (Forward)-0.41
52W Range
1.07017% of range2.730
52W High2.730 USD
52W Low1.070 USD
Profitability
Gross Margin28.61%
Oper. Margin-114.36%
EBITDA Margin125.06%
Profit Margin-341.47%
ROE-10214.54%
ROA-69.68%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.21M $
CapEx (TTM)7.71M $
FCF Margin183.11%
FCF Yield69.50%
Net Debt472.25M $
Net Debt/EBITDA2.37
Balance Sheet
Debt/Equity131.32
Current Ratio4.92
Quick Ratio3.90
Book Value/Sh-0.1070 USD
Cash/Share0.7620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.292 USD
Upside (mean)+69.8%
Target Range1.250 USD – 3.000 USD
$1.250+69.8% to mean$3.000
# Analysts6
Ownership
Shares Out.310.83M
Float304.06M
Insiders8.91%
Institutions55.28%
Short Interest
Short Ratio8.4d
Short % Float18.12%
Short % Out.15.77%
Shares Short49.00M
Short (prev mo.)47.49M
Technical
SMA 501.399 (-3.5%)
SMA 2001.660 (-18.7%)
Beta2.32
S&P 52W Chg18.16%
Avg Vol (30d)6.94M
Avg Vol (10d)7.15M
Technical Indicators
RSI (14)53.0
MACD-0.0589
MACD Signal-0.0686
MACD Hist.+0.0097
BB Upper1.535 USD
BB Middle1.292 USD
BB Lower1.048 USD
BB Width37.76%
ATR (14)0.0973 USD
Vol Ratio (20d)0.96x